The complexity of the complicity of mast cells in cancer

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 5, 2010, Pages 551-554

  Nechushtan, Hovav ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; c Kit; Cancer; Mast cells; Tyrosine kinase inhibitors

Indexed keywords

IMATINIB; MASITINIB; PAZOPANIB; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR RECEPTOR; SUNITINIB; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CELL SECRETION; DRUG DESIGN; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOCOMPETENT CELL; MAST CELL; NEOPLASM; NONHUMAN; SHORT SURVEY; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; HUMANS; MAST CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEUROFIBROMATOSIS 1; PROGNOSIS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT;

ANIMALIA;

EID: 77649189956     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.12.015     Document Type: Short Survey

References (20)

1. Beaven M.A. Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 39 (2009) 11-25
2. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 (1999) 1382-1397
3. Cristofanilli M., Morandi P., Krishnamurthy S., Reuben J.M., Lee B.N., Francis D., et al. Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations. Ann Oncol 19 (2008) 1713-1719
4. Galinsky D.S., and Nechushtan H. Mast cells and cancer-no longer just basic science. Crit Rev Oncol Hematol 68 (2008) 115-130
5. Galli S.J., Tsai M., Wershil B.K., Tam S.Y., and Costa J.J. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol 107 (1995) 51-53
6. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
7. Lu X., Nechushtan H., Ding F., Rosado M.F., Singal R., Alizadeh A.A., et al. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 105 (2005) 2924-2932
8. Maltby S., Khazaie K., and McNagny K.M. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 796 (2009) 19-26
9. McNeil H.P., Adachi R., and Stevens R.L. Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J Biol Chem 282 (2007) 20785-20789
10. Mussi C., Schildhaus H.U., Gronchi A., Wardelmann E., and Hohenberger P. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res 14 (2008) 4550-4555
11. Nakayama T., Yao L., and Tosato G. Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J Clin Invest 114 (2004) 1317-1325
12. Nishimoto H., Lee S.W., Hong H., Potter G., Maeda-Yamamoto M., Kinoshita T., et al. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106 (2005) 4241-4248
13. Peng S.H., Deng H., Yang J.F., Xie P.P., Li C., Li H., et al. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 11 (2005) 6521-6524
14. Samoszuk M., Kanakubo E., and Chan K. Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5 (2005) 121
15. Schilder R.J., Sill M.W., Lee R.B., Shaw T.J., Senterman M.K., Klein-Szanto A.J., et al. Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 26 (2008) 3418-3426
16. Soucek L., Lawlor E.R., Soto D., Shchors K., Swigart L.B., and Evan G.I. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13 (2007) 1211-1218
17. Stevens R.L., and Adachi R. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity. Immunol Rev 217 (2007) 155-167
18. Taube C., and Stassen M. Mast cells and mast cell-derived factors in the regulation of allergic sensitization. Chem Immunol Allergy 94 (2008) 58-66
19. Welsh T.J., Green R.H., Richardson D., Waller D.A., O'Byrne K.J., and Bradding P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23 (2005) 8959-8967
20. +/- and c-kit-dependent bone marrow. Cell 135 (2008) 437-448